跳至主要内容
临床试验/NCT01332435
NCT01332435已完成不适用

Dutasteride in Enlarged Prostate Economic Assessment: A Retrospective Database Pooled Analysis of Early 5-alpha Reductase Inhibitor Use

GlaxoSmithKline0 个研究点目标入组 6,896 人开始时间: 2009年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
6,896
主要终点
Number of Participants With Clinical Progression

研究概览

简要总结

This retrospective study aims to assess the economic impact of early initiation of 5-alpha-reductase inhibitor (5ARI) therapy in patients with enlarged prostate (EP) receiving 5ARI and alpha-blocker (AB) combination therapy. Both the Integrated Health Care Information Solutions and PharMetrics databases will be utilized for this study (2000-2007).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Male patients aged 50 years or older
  • a medical claim of EP
  • a prescription claim for a 5ARI and AB (provided both are within 180 days of index date)
  • continuously eligible for 6 months prior to and at least 12 months after index prescription date.

排除标准

  • diagnosis of prostate or bladder cancer
  • any prostate-related surgical procedure within 5 months of index date
  • prescription claim for finasteride indicative of male pattern baldness
  • 5ARI therapy initiated prior to initiating AB therapy

研究组 & 干预措施

Early 5ARI Initiation

Patients with EP receiving combination therapy (AB + 5ARI) with early initiation of 5ARI (within 30 days of initiation of AB)

干预措施: 5ARI + AB (Drug)

Late 5ARI Initiation

Patients with EP receiving combination therapy (AB + 5ARI) with late initiation of 5ARI (more than 30 days but less than 6 months after initiation of AB)

干预措施: 5ARI + AB (Drug)

结局指标

主要结局

Number of Participants With Clinical Progression

时间窗: Day 1 of a 1-day study

Clinical progression was identified as the occurrence of acute urinary retention and/or surgery as identified by relevant Common Procedure Terminology (CPT) procedure codes and International Classification of Diseases (ICD)-9CM diagnosis codes.

Number of Participants With Acute Urinary Retention

时间窗: Day 1 of a 1-day study

Acute urinary retention was identified by relevant CPT procedure codes and ICD-9CM diagnosis codes.

Number of Participants Who Needed Prostate-Related Surgery

时间窗: Day 1 of a 1-day study

Prostate-related surgery was identified by relevant CPT procedure codes and ICD-9CM diagnosis codes.

次要结局

  • Total BPH-related Costs(Day 1 of a 1-day study)
  • BPH-related Medical Costs(Day 1 of a 1-day study)
  • BPH-related Pharmacy Costs(Day 1 of a 1-day study)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验